政府管制下医药行业供应链合作及收益分配分析_吕红.pdfVIP

药物经济 《 中国卫生经济》 第 卷第 期 （总第 期） 年 月 □ 31 3 349 2012 3 政府管制下医药行业供应链合作及收益分配分析 ① 吕 红 摘 要 在新医改政策背景下， 以一个药品生产商与两个销售商为医药供应链的基本研究对象， 探讨政府管制对不同合作 方式及利益分配的影响： 模型对药品生产商与两个医药销售商协议合作； 药品生产商与 个销售商协议合作， 与另一个销 ⑴ ⑵ 1 售商物流合作； ⑶药品生产商与两个销售商都进行物流合作三种合作。 对这方式及利润分配情况进行研究， 结果表明， 不同合 作方式下的企业利润分配有较大差异， 管制政策的实施在一定程度上降低了医药供应链的行业利润， 并对医药企业提高流通效 率产生积极影响。 关键词 医药行业； 政府管制； 供应链合作； 收益分配 中图分类号 R1-9 ； R197.1 文献标识码 A 文章编号 1003-0743(2012)03-0035-03 Effects of Government Regulations on the Medicine Industry Supply Chain Cooperation and the Profits Distribution/L譈 Hong//Chinese Health Economics, 2012,31(3): 35-37 Abstract A two-stage supply chain consisting of a manufacture and 2 sales was exampled to analyze the influence of government regulations on the cooperation models and their profit allocations. Three kinds of modalities of cooperation were given: ⑴ a manufacture cooperating with two sales on agreement respectively; ⑵a manufacture cooperating with a sale on agreement and with another on logistic; ⑶ a manufacture cooperating with two sales on logistic respectively. It ’s proved that the government regulation policies can change the cooperation models in Chinese medicine supply chain, limit the extraordinary profits in medicine distributions, and urge firms to improve their distribution and logistics management. Key words medicine industry; government regulation; supply chain cooperation; profit distribution ’